Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 19767198

Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2009 Nov
First author
Constantinidou A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2009 Nov;45(17):2928-9. doi: 10.1016/j.ejca.2009.09.012.
    note
    Source null
    related pmid
    19804964
    relationship
    Comment in

Authors and identifiers

  1. name
    Constantinidou A
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    Scurr M
    type
    Author
  4. name
    Al-Muderis O
    type
    Author
  5. name
    Judson I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Constantinidou A
    type
    Author
  2. name
    Jones RL
    type
    Author
  3. name
    Scurr M
    type
    Author
  4. name
    Al-Muderis O
    type
    Author
  5. name
    Judson I
    type
    Author
bibliography ids
  1. nci-bib-7a1dd22b801b1869c572edfd
book metadata
content sha256
eab15958ceb52b985286d063f1f7514ccfb437b6f83f1d7ac42024116f64a586
document type
citation
dois
  1. 10.1016/j.ejca.2009.08.016
electronic publication date
display
2009 Sep 18
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19767198
immutable id
pubmed:19767198@eab15958ceb52b985286d063f1f7514ccfb437b6f83f1d7ac42024116f64a586
journal
abbreviation
Eur J Cancer
issn electronic
1879-0852
issn print
0959-8049
issue
17
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
2930-4
volume
45
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2009 Nov;45(17):2928-9. doi: 10.1016/j.ejca.2009.09.012.
    note
    Source null
    related pmid
    19804964
    relationship
    Comment in
outcomes validated
false
pmid
19767198
provenance
batch id
0706b5111d1451f52f74
provider
NCBI PubMed ESummary
record sha256
c6953ab3b93326d2f3eefc80c5fe2e3898807e29caa64e7b1e70c9884499d561
response sha256
98b7635e326dbc32198e6976da57b1b6c18df77505740dee0ce67d80260cda70
retrieved at
2026-09-09T23:46:29.215195+00:00
publication date
display
2009 Nov
precision
month
year
2009
publication types
  1. Clinical Trial
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19767198/
title
Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis.

Preserved source evidence · Not medical advice